Blood tests and swallowing exercise check-ins for head and neck cancer
Part of Cancer, Ear, nose & throat, Lungs & breathing, Mouth & dental clinical trials.
This study looks at whether giving swallowing exercises and checking in with questionnaires can help people with metastatic (spreading to neck lymph nodes) head and neck cancers do the exercises correctly. It also uses blood tests to better understand adherence and progress over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to get radiation aimed to cure your cancer in the head/neck
- Your cancer is in specific areas: nasopharynx, oropharynx, hypopharynx, larynx, or an unknown primary with neck lymph node spread
- Your cancer stage matches one of the listed ranges (stage I to IVb, with specific notes for HPV-related oropharynx cancers)
- You have no cancer besides your current head/neck cancer (except non-melanoma skin cancer)
- You have not had prior head/neck cancer treatment or prior radiation to the head/neck
- You have not had head/neck surgery before, aside from biopsy, tonsil removal, or tracheotomy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how physical activity (movement during the day) and a clinician-rated “day-to-day function” score relate to overall survival in people with certain cancers. It may help doctors understand who benefits most from activity-focused care and better monitoring.
This Phase 2 study tests whether giving a less intense (de-escalated) radiation plan can work for certain people with HPV-related oropharyngeal throat cancer. It uses HPV blood testing and scans to help guide treatment, aiming to keep cancer control while reducing treatment side effects.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
This study looks at certain markers (called p16 and HPV) in tumor samples to better understand oropharynx cancer. It may help doctors learn more about the disease and guide future treatments.
This Phase 2 study tests a “risk-adapted” treatment plan for HPV-related throat cancer, using an HPV DNA blood test to help decide how treatment is done. If your baseline blood test shows detectable HPV DNA, the study may help tailor therapy to your risk and potentially improve outcomes while limiting unnecessary treatment.
This study tests a remote hearing test to monitor hearing changes in patients with head and neck cancer getting cisplatin chemotherapy and/or radiation. The goal is to catch hearing loss early so treatment can be adjusted.
Hear when a new Stage II Laryngeal Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.